EU Court Of Justice: EU Is Competent To Ratify Marrakesh Treaty 14/02/2017 by Catherine Saez, Intellectual Property Watch 3 Comments The European Union ratification of a treaty allowing an exception to copyright for the benefit of visually impaired people might be yet one step closer as the Court of Justice of the EU found today that the EU has exclusive competence to conclude it.
European Parliament Demands Transparency In Expert Groups, Protection For Whistleblowers 14/02/2017 by Monika Ermert for Intellectual Property Watch 1 Comment The European Commission is reforming the way it populates its “expert groups” which has been criticized as unbalanced and non-transparent for years. But the European Parliament is not satisfied. In a report on its own initiative passed in Strasbourg today practically unanimously (663 in favour, 16 against, 13 abstentions), the Parliament requested the Commission make public how it decides the composition of expert groups and explain which interest groups are to be represented and how geographical and political interests will be balanced.
Hepatitis C Patent Challenges In India, Argentina To Allow Generic Production 14/02/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment Resistance to high prices for hepatitis C drugs is ongoing as five new challenges against patents have been filed in India and Argentina, according to sources. Those challenges aim at allowing the production and distribution of affordable generic versions of new hepatitis C medicines (direct-acting antivirals).
Fashion Law – New US/EU Legislation And Retailers: Customer Data And Trademarks 14/02/2017 by Kim Treanor for Intellectual Property Watch Leave a Comment NEW YORK — The fourth annual Fashion Law Seminar, organised by the Federal Bar Association Intellectual Property Section, presented on new legislation in the United States and European Union, and its potential impact on domestic and transnational retailers.
The Problem With Rare Diseases: R&D Lacking, High Prices, Discrimination, IP Issues 13/02/2017 by Catherine Saez, Intellectual Property Watch 1 Comment Over 6,000 rare diseases, those affecting very small populations, have been documented in the world. For those affected, treatments are mostly non-existent, and if they do exist, are not affordable. An event last week gathered a number of stakeholders, including rare disease organisations, the World Health Organization and the pharmaceutical industry to discuss the particular issue of rare diseases. The case of rare diseases is an exacerbated example of research, pricing, accessibility and affordability.
New Policies On Technology Transfer In China: Granting More Autonomy To Universities 10/02/2017 by Guest contributor for Intellectual Property Watch 1 Comment According to a recent circular released by the Chinese ministries of education, and science and technology, universities established by the state have autonomy in technology transfer (see the original news here). Unless the scientific and technological achievements concern national security, national interests, and major public interests, it is unnecessary to report to the ministry of finance or management department. All income gained from the technology transfer belongs to the universities.
Leadership Rotation For Fight The Fakes Campaign 09/02/2017 by Intellectual Property Watch 1 Comment A new industry group today took the reins of the Fight the Fakes campaign, a growing coalition against fake medicines, the first rotation in leadership since its launch in late 2013.
Patentability Of Some Biotech Uncertain In Europe As Examination, Opposition Suspended 09/02/2017 by Catherine Saez, Intellectual Property Watch 1 Comment The patentability of plants or animals that have been obtained by natural occurrence such as selection and crossing has been a recurrent issue discussed at the European Patent Office (EPO). A recent notice from the European Commission challenged a ruling by the EPO Enlarged Board of Appeal on such patents, prompting yet more discussions in the organisation. In the meantime, all examination and opposition on such patents have been halted at the EPO. Industry is concerned that the EPO ruling might be questioned, and warns of effects on innovation, harm to applicants. Civil society is concerned about a non-transparent process.
WIPO Broadcasting Treaty: What Broadcasters Really Want To Protect Their Business From Piracy 09/02/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment In discussion for close to 16 years at the World Intellectual Property Organization, a treaty aimed at protecting broadcasting organisations’ intellectual property rights has not reached conclusion. Intellectual Property Watch sat down recently with the European Broadcasting Union to understand what broadcasters actually say they need to protect their businesses against piracy. As to what they see hindering the technical resolution of the treaty? Politics.
US Chamber International IP Index: US, Europe At Top; India Needs A Push 08/02/2017 by William New, Intellectual Property Watch 2 Comments The United States Chamber of Commerce today released its fifth annual International IP Index, which makes the case for the positive impact of intellectual property on economies. The United States scored highest, followed by top European economies and Japan. And near the bottom was India, despite recent efforts to accept the IP system. Separately, the report assesses international trade rules for IP and argues for nations to negotiate “TRIPS-plus” agreements.